Actor Christina Applegate revealed on October 20, 2026, during a two-part episode of her podcast MeSsy, that a medical evaluation determined she does not have multiple sclerosis, reversing a diagnosis she first shared publicly in 2021 as reported by PBS NewsHour. The revelation brings a complex twist to five years during which the actor integrated her condition into her public identity, career, and advocacy work.

The Turning Point and Medical Re-Evaluation

The realization that Applegate had been misdiagnosed came after her doctor chose to pause her ongoing B-cell infusion treatments to observe how her immune system would respond without them. According to details covered by CBS News, the lack of expected disease progression or change during this observation period prompted medical professionals to re-examine the original findings. The process left Applegate returning to what she described as square one, without a clear answer for the severe physical challenges she continues to face.

Despite the reversal of her medical label, Applegate continues to experience severe neurological symptoms. These include chronic numbness, tingling, weakness, difficulty walking, and vision problems. Her mobility limitations have required her to use a cane or wheelchair, a reality that also shaped her recent professional life, such as when her scripts and filming schedules on Netflix's Dead to Me were adjusted to accommodate her physical state.

Unresolved Symptoms and Personal Impact

Without an accurate diagnosis to explain her ongoing health struggles, Applegate has expressed deep confusion and disappointment. She noted feelings of having let people down after years of serving as a prominent voice for the MS community. The sudden shift in her medical understanding also led her to temporarily pause production on her podcast to process the news.

Over the years following her initial 2021 announcement, Applegate has faced heavy medical hurdles, including multiple hospitalizations—such as a four-month stay earlier in 2026—and a physical therapy regimen maintained three times a week. These challenges ran parallel to her creative output, including the March 2026 publication of her memoir, You With the Sad Eyes.

The Broader Context of Neurological Misdiagnosis

Applegate's experience highlights a wider diagnostic challenge within neurology. According to data from the National Multiple Sclerosis Society noted by ABC News, systematic reviews estimate that misdiagnosis rates for the condition can range anywhere from 5% to 41%. Furthermore, specialists like Dr. Marwa Kaisey, an associate professor at Cedars-Sinai, have pointed out that up to 20% of individuals initially labeled with multiple sclerosis may actually be suffering from entirely different underlying conditions.

As Applegate pursues further medical investigation to uncover the root cause of her persistent neurological symptoms, the exact path forward remains open. With her B-cell treatments halted and her previous diagnosis dismantled, the immediate focus turns toward identifying the true origin of her physical struggles while navigating the personal fallout of a heavily publicized medical correction.